URL details: www.pumabiotechnology.com/pr20220606.html

home > domains > pumabiotechnology.com > www.pumabiotechnology.com/pr20220606.html

URL title: Puma Biotechnology
URL description: Puma Biotechnology, Inc. is a biopharmaceutical company dedicated to the acquisition, development and commercialization of novel therapeutics for the treatment of cancer. Puma in-licenses the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357. Neratinib, oral was approved by the U.S. Food and Drug Administration (FDA) in 2017 for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer,
URL keywords: Biotechnology, development stage, biopharmaceutical, in-licensing, cancer treatment, discovery and development of therapeutics,
URL last crawled: 2022-08-30
URL speed: 0.148 MB/s, downloaded in 0.200 seconds

open external url

We found no external links pointing to this url.